TY - JOUR
T1 - A metabolomic profile of biological aging in 250,341 individuals from the UK Biobank
AU - Zhang, Shiyu
AU - Wang, Zheng
AU - Wang, Yijing
AU - Zhu, Yixiao
AU - Zhou, Qiao
AU - Jian, Xingxing
AU - Zhao, Guihu
AU - Qiu, Jian
AU - Xia, Kun
AU - Tang, Beisha
AU - Mutz, Julian
AU - Li, Jinchen
AU - Li, Bin
N1 - Publisher Copyright:
© 2024. The Author(s).
PY - 2024/9/15
Y1 - 2024/9/15
N2 - The metabolomic profile of aging is complex. Here, we analyse 325 nuclear magnetic resonance (NMR) biomarkers from 250,341 UK Biobank participants, identifying 54 representative aging-related biomarkers associated with all-cause mortality. We conduct genome-wide association studies (GWAS) for these 325 biomarkers using whole-genome sequencing (WGS) data from 95,372 individuals and perform multivariable Mendelian randomization (MVMR) analyses, discovering 439 candidate "biomarker - disease" causal pairs at the nominal significance level. We develop a metabolomic aging score that outperforms other aging metrics in predicting short-term mortality risk and exhibits strong potential for discriminating aging-accelerated populations and improving disease risk prediction. A longitudinal analysis of 13,263 individuals enables us to calculate a metabolomic aging rate which provides more refined aging assessments and to identify candidate anti-aging and pro-aging NMR biomarkers. Taken together, our study has presented a comprehensive aging-related metabolomic profile and highlighted its potential for personalized aging monitoring and early disease intervention.
AB - The metabolomic profile of aging is complex. Here, we analyse 325 nuclear magnetic resonance (NMR) biomarkers from 250,341 UK Biobank participants, identifying 54 representative aging-related biomarkers associated with all-cause mortality. We conduct genome-wide association studies (GWAS) for these 325 biomarkers using whole-genome sequencing (WGS) data from 95,372 individuals and perform multivariable Mendelian randomization (MVMR) analyses, discovering 439 candidate "biomarker - disease" causal pairs at the nominal significance level. We develop a metabolomic aging score that outperforms other aging metrics in predicting short-term mortality risk and exhibits strong potential for discriminating aging-accelerated populations and improving disease risk prediction. A longitudinal analysis of 13,263 individuals enables us to calculate a metabolomic aging rate which provides more refined aging assessments and to identify candidate anti-aging and pro-aging NMR biomarkers. Taken together, our study has presented a comprehensive aging-related metabolomic profile and highlighted its potential for personalized aging monitoring and early disease intervention.
UR - http://www.scopus.com/inward/record.url?scp=85204167926&partnerID=8YFLogxK
U2 - 10.1038/s41467-024-52310-9
DO - 10.1038/s41467-024-52310-9
M3 - Article
SN - 2041-1723
VL - 15
SP - 8081
JO - Nature Communications
JF - Nature Communications
IS - 1
ER -